217 related articles for article (PubMed ID: 11881984)
1. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
McCluskey A; Sim AT; Sakoff JA
J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984
[No Abstract] [Full Text] [Related]
2. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].
Takai A
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1091-101. PubMed ID: 9655967
[No Abstract] [Full Text] [Related]
3. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
[TBL] [Abstract][Full Text] [Related]
4. [Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
Suganuma M; Fujiki H
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1102-10. PubMed ID: 9655968
[No Abstract] [Full Text] [Related]
5. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW
J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439
[TBL] [Abstract][Full Text] [Related]
6. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
Ubukata M; Koshino H; Yamasaki C; Fujita K; Isono K
J Antibiot (Tokyo); 1997 Oct; 50(10):801-7. PubMed ID: 9402983
[No Abstract] [Full Text] [Related]
7. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung.
Bastan R; Peirce MJ; Peachell PT
Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
Dawson JF; Holmes CF
Front Biosci; 1999 Oct; 4():D646-58. PubMed ID: 10502549
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.
Ford SL; Abayasekara DR; Persaud SJ; Jones PM
J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587
[TBL] [Abstract][Full Text] [Related]
10. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
Fujiki H; Suganuma M
Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
[No Abstract] [Full Text] [Related]
11. [Total synthesis and conformational analysis of inhibitors].
Tsuboi K; Isobe M
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1083-90. PubMed ID: 9655966
[No Abstract] [Full Text] [Related]
12. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A.
MacKintosh C; Klumpp S
FEBS Lett; 1990 Dec; 277(1-2):137-40. PubMed ID: 2176611
[TBL] [Abstract][Full Text] [Related]
13. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.
Fladmark KE; Brustugun OT; Hovland R; Boe R; Gjertsen BT; Zhivotovsky B; Døskeland SO
Cell Death Differ; 1999 Nov; 6(11):1099-108. PubMed ID: 10578179
[TBL] [Abstract][Full Text] [Related]
14. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.
Walsh AH; Cheng A; Honkanen RE
FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.
Swingle M; Ni L; Honkanen RE
Methods Mol Biol; 2007; 365():23-38. PubMed ID: 17200551
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors.
Wipf P; Aslan DC; Luci DK; Southwick EC; Lazo JS
Biotechnol Bioeng; 2000; 71(1):58-70. PubMed ID: 10629537
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bile acid transport: beyond molecular cloning.
Dranoff JA; Nathanson MH
Hepatology; 1999 Jun; 29(6):1912-3. PubMed ID: 10347140
[No Abstract] [Full Text] [Related]
19. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development.
Troll W; Sueoka N; Sueoka E; Laskin JD; Heck DE
Biol Bull; 1995; 189(2):201. PubMed ID: 8541399
[No Abstract] [Full Text] [Related]
20. Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study.
Oikawa H
Curr Med Chem; 2002 Nov; 9(22):2033-53. PubMed ID: 12369869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
